Dermatology Online Journal 2014-Aug
Hydroxyurea-induced amyopathic dermatomyositis presenting with heliotrope erythema.
只有注册用户可以翻译文章
登陆注册
链接已保存到剪贴板
关键词
抽象
Hydroxyurea (HU) is a chemotherapeutic agent used for the treatment of myeloproliferative disorders such as chronic myeloid leukemia, polycythemia vera, and essential thrombocytosis. We describe a 69-year-old man who had essential thrombocytosis and developed amyopathic dermatomyositis after long-term HU therapy. He presented with Gottron papules and heliotrope erythema. The former has been described in all cases of HU-induced dermatomyositis; the latter has been seen in a few cases of that disorder.